Article Data

  • Views 586
  • Dowloads 140

Case Reports

Open Access

Undifferentiated endometrial sarcoma of the cervix: a case report

  • P.-S. Huang1,6,7
  • C.-T. Yue2
  • W.-Y. Kao3
  • J.-M. Hwang4
  • H.-W. Kuo5
  • S.-C. Huang1,*,

1Department of Obstetrics and Gynecology,Taiwan(China)

2Department of Pathology,Taiwan(China)

3Department of Hematology and Oncology,Taiwan(China)

4Department of Radiation Oncology, Taiwan(China)

5Department of Diagnostic Radiology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, TaipeiTaiwan(China)

6Department of Obstetrics and Gynecology, College of Medicine, Taipei Medical University, Taipei,Taiwan(China)

7Department of Obstetrics and Gynecology, Taipei Medical University Hospital, Taipei ,Taiwan(China)

DOI: 10.12892/ejgo4646.2019 Vol.40,Issue 6,December 2019 pp.1035-1038

Published: 10 December 2019

*Corresponding Author(s): S.-C. Huang E-mail: schuang@tzuchi.com.tw

Abstract

Undifferentiated endometrial sarcoma is an aggressive sarcoma. The authors report a case of such a large tumor arising from the cervix in a 53-year-old multiparous woman presenting with urinary retention and vaginal bleeding. Ultrasound and Doppler imaging revealed a large mass about 13.3×7.6 cm in the cervix. MRI revealed a large polypoid heterogeneous hyperintensity tumor (12.2×8.2 cm) in the cervix with vaginal lumen protrusion and urinary bladder compression. Total abdominal hysterectomy and bilateral salp-ingo-oophorectomy were performed. The pathology revealed FIGO Stage IIb. Adjuvant radiotherapy and chemotherapy with doxorubicin were given. The patient tolerated the treatment well, and so far she has no evidence of recurrence.

Keywords

Undifferentiated endometrial sarcoma; Vaginal bleeding; Hysterectomy.

Cite and Share

P.-S. Huang,C.-T. Yue,W.-Y. Kao,J.-M. Hwang,H.-W. Kuo,S.-C. Huang. Undifferentiated endometrial sarcoma of the cervix: a case report. European Journal of Gynaecological Oncology. 2019. 40(6);1035-1038.

References

[1] D’Angelo E., Prat J.: “Uterine sarcomas: a review”. Gynecol. Oncol., 2010, 116, 131.

[2] Hendrickson M.R., Tavassoli F.A., Kempson R.L., et al.: “Mes-enchymal tumours and related lesions. In: Tavassoli FA, Devilee P,(eds). World Health Organization Classification of Tumours. Pathol-ogy and Genetics of Tumours of the Breast and Female Genital Or-gans. Lyon: IARC Press, 2003, 233.

[3] Chew I., Oliva E.: “Endometrial stromal sarcomas. A review of po-tential prognostic factors”. Adv. Anat. Pathol., 2010, 17, 113.

[4] Tanner E.J., Garg K., Leitao M.M. Jr., Soslow R.A., Hensley M.L.: “High grade undifferentiated uterine sarcoma: surgery, treatment, and survival outcomes”. Gynecol. Oncol., 2012, 127, 27.

[5] Abell M.R., Ramirez J.A.: “Sarcomas and carcinomas of the uterine cervix”. Cancer, 1973, 31, 1176.

[6] Chang K.I., Crabtree G.S., Lim-Tan S.K., Kempson R.L., Hendrick-son M.R.: “Primary extrauterine endometrial stromal neoplasms: a clinicopathologic study of 20 cases and a review of the literature”. Int. J. Gynecol. Pathol., 1993, 12, 282.

[7] Clement P.B., Young R.H., Scully R.E.: “Stromal endometriosis of the uterine cervix. A variant of endometriosis that may simulate sar-coma”. Am. J. Surg. Pathol., 1990, 14, 449.

[8] Prat J.: “FIGO staging for uterine sarcoma”. Int. J. Gynecol. Obstet., 2009, 104, 177.

[9] Gadducci A., Cosio S., Romanini A., Genazzani A.R.: “The man-agement of patients with uterine sarcoma: a debated clinical chal-lenge”. Crit. Rev. Oncol. Hematol., 2008, 65, 129.

[10] Orr B.C., Lin J.F., Edwards R.P., Kelley J.L. III, Olawaiye A.B., Comerci J.T., et al.: “Undifferentiated endometrial sarcoma: Does adjuvant treatment impact outcomes of stage I disease?” Gynecol. Oncol., 2016, 141, 120.

[11] Williams G.A., Richardson A.C.: “Endometriosis of the cervix. Clas-sification and analysis of 17 cases”. Am. J. Obstet. Gynecol., 1961, 81, 111.

[12] Veigo-Ferreira M.M., Leiman G., Dunber F., Margolius K.A.: “Cer-vical endometriosis facilitated diagnosis by fine needle aspiration cytologic testing”. Am. J. Obstet. Gynecol., 1987, 157, 849.

[13] Chen X., Hamele-Bena D., Galic V.L., Liu-Jarin X., Ko Y.C.K., Her-zog T., et al.: ‘Infiltrating adenomyosis of the cervix with features of a low-grade stromal sarcoma: a case report and a literature re-view”. Int. J. Gynecol. Pathol., 2014, 33, 253.

[14] Puliyath G., Nair M.K.: ‘Endometrial stromal sarcoma: A review of the literature”. Indian J. Med. Paediatr. Oncol., 2012, 33, 1.

[15] Shah S.H., Jagannathan J.P., Krajewski K., O’Regan K.N., George S, Ramaiya N.H.: “Uterine sarcomas: then and now”. Am. J. Roentgenol., 2012, 199, 213.

[16] Toprak U., Paşaoğlu E., Karademir M.A., Gülbay M.: “Sonographic, CT, and MRI findings of endometrial stromal sarcoma located in the myometrium and associated with peritoneal inclusion cyst”. Am. J. Roentgenol., 2004, 182, 1531.

[17] Kim J.A., Lee M.S., Choi J.S.: “Sonographic findings of uterine en-dometrial stromal sarcoma”. Korean J. Radiol., 2006, 7, 281.

[18] Tepper R., Altaras M., Goldberger S., Zalel Y., Cordoba M., Beyth Y.: “Color Doppler ultrasonographic findings in low and high grade endometrial stromal sarcomas”. J. Ultrasound Med., 1994, 13, 817.

[19] Rha S.E., Byun J.Y., Jung S.E., Lee S.L., Cho S.M., Hwang S.S., et al.: “CT and MRI of Uterine Sarcomas and Their Mimickers”. Am. J. Roentgenol., 2003, 181, 1369.

[20] Nucci M.R., Harburger D., Koontz J., Dal Cin P., Sklar J.: “Molec-ular analysis of the JAZF1-JJAZ1 gene fusion by RT-PCR and fluo-rescence in situ hybridization in endometrial stromal neoplasms”. Am. J. Surg. Pathol., 2007, 31, 65.

[21] Lange S.S., Novetsky A.P., Powell M.A.: “Recent advances in the treatment of sarcomas in gynecology”. Discov. Med., 2014, 18, 133.

[22] Amant F., De Knijf A., Van Calster B., Leunen K., Neven P., Berteloot P., et al.: “Clinical study investigating the role of lym-phadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma”. Br. J. Cancer, 2007, 97, 1194.

[23] Reed N.S., Mangimni C.. Malmstrom H., Scarfone G., Poveda A., Pecorelli S., et al.: “Phase III randomized study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcoma stage I and IIL an European Organization for Research and Treat-ment of Cancer Gynaecological Cancer Group Study (protocol 55874)”. Eur J. Cancer, 2008, 44, 808.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top